Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
Go back to Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs| (NASDAQ: BCTX) | Delayed: 3.56 +0.06 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.50 | 52 Week High | $ | |||
| Open | $3.47 | 52 Week Low | $ | |||
| Day High | $3.64 | P/E | N/A | |||
| Day Low | $3.45 | EPS | $ | |||
| Volume | 49,882 | |||||
| (NASDAQ: NTHI) | Delayed: 3.00 +0.18 (6.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.82 | 52 Week High | $ | |||
| Open | $2.80 | 52 Week Low | $ | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.79 | EPS | $ | |||
| Volume | 69,923 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.46 -0.01 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $1.37 | |||
| Open | $0.47 | 52 Week Low | $0.24 | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $0.00 | |||
| Volume | 856,314 | |||||



